ACAD
NASDAQ · Biotechnology
Acadia Pharmaceuticals Inc
$22.09
+0.47 (+2.17%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
-20.02%
1Y
-1.73%
YTD
-15.98%
Open$21.64
Previous Close$21.62
Day High$22.46
Day Low$21.59
52W High$28.35
52W Low$19.69
Volume—
Avg Volume1.27M
Market Cap3.70B
P/E Ratio9.86
EPS$2.19
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$25.91
Below
SMA 200
$23.44
Below
RSI (14)
42.4
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
27 analysts
Price Target
-19.0% upside
Current
$22.09
$22.09
Target
$17.90
$17.90
$12.70
$17.90 avg
$23.84
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.08B | 948.62M | 1.03B |
| Net Income | 394.03M | 311.54M | 167.73M |
| Profit Margin | 36.5% | 34.7% | 16.3% |
| EBITDA | 106.51M | 88.89M | 233.13M |
| Free Cash Flow | — | — | 189.95M |
| Rev Growth | +13.8% | +13.8% | +10.0% |
| Debt/Equity | — | — | 0.91 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $230.01 | +6.25% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $344.72 | +2.11% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $124.87 | +0.90% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $466.79 | +3.36% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $612.50 | +0.42% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $286.41 | +2.99% | 64.3 | 37.13B |